focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Pin to quick picksBYOT.L Share News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Byotrol sells American rights to antimicrobial formulation

Fri, 01st Oct 2021 10:30

(Sharecast News) - Byotrol said on Friday that it has completed the sale in the Americas of its US Environmental Protection Agency (EPA)-registered, long-lasting antimicrobial surface spray to its existing licensee, Integrated Resources (IRI).
The AIM-traded firm said the agreement involved a sale to IRI of all rights to the formulation in the Americas, including registrations and patent rights, in return for cash payments of $1.4m in total, paid over a maximum of two years, with the first payment already made.

For US regulatory reasons, Byotrol would remain the formal, legal owner of the formulation until the payments were complete, although substantially all economic risks and rewards had now been transferred to IRI.

The company said it would also receive three years of royalty on all IRI sales, as well as further payments should IRI on-sell the formulation within three years.

Byotrol would also still act as the preferred technical services provider to IRI and its customers on the formulation, paid-for by IRI on a case-by-case basis.

Simultaneous with the sale, Byotrol said it had entered into a preliminary three-way agreement with IRI and a "significant" US distribution company to register with the EPA and then sell the formulation into US professional markets.

Should formal registration be achieved, sales by IRI to the distributor would accrue additional royalties to Byotrol.

Byotrol said it retained all ownership and rights over the formulation outside the Americas.

The agreement continued the company's strategy to cease its day-to-day operations in the US, the board explained, while maintaining rights to share in the success of its partners and licensees.

"Byotrol24 is going to a very good home in Integrated Resources, and we look forward to sharing in their continuing successes in the Americas.," said chief executive officer David Traynor.

"We are particularly pleased with the new relationships IRI has been building - and that we have been helpful in securing - in the last 18 months and we expect them to accelerate progress now, particularly in the very large US markets, helping to underpin management's expectations for the current and next financial year."

At 1012 BST, shares in Byotrol were down 1.14% at 4.35p.
More News
8 Sep 2015 07:19

LONDON BRIEFING: Amlin Agrees To Be Bought By Mitsui Sumitomo Insurance

Read more
8 Sep 2015 05:12

AGM, EGM Calendar - Week Ahead

Read more
7 Sep 2015 15:04

AGM, EGM Calendar - Week Ahead

Read more
7 Sep 2015 05:15

AGM, EGM Calendar - Week Ahead

Read more
4 Sep 2015 15:16

AGM, EGM Calendar - Week Ahead

Read more
4 Sep 2015 05:22

AGM, EGM Calendar - Week Ahead

Read more
3 Sep 2015 15:04

AGM, EGM Calendar - Week Ahead

Read more
3 Sep 2015 05:17

AGM, EGM Calendar - Week Ahead

Read more
2 Sep 2015 15:15

AGM, EGM Calendar - Week Ahead

Read more
2 Sep 2015 05:15

AGM, EGM Calendar - Week Ahead

Read more
1 Sep 2015 15:25

AGM, EGM Calendar - Week Ahead

Read more
20 Aug 2015 12:03

Byotrol Raises GBP1.4 Million To Back Sales And Marketing Expansion (ALLISS)

Read more
4 Aug 2015 12:05

Byotrol agrees commercialisation deal with Belgian giant Solvay

(ShareCast News) - Byotrol has strengthened its links with Belgian chemicals group Solvay with a new agreement to develop and commercialise long-lasting biocidal products. As part of the deal, Solvay will make a "significant" investment in Byotrol's technical cost base in the current financial year.

Read more
4 Aug 2015 07:25

Byotrol Shares Rise As It Inks Biocidal Products Deal With Solvay

Read more
28 Jul 2015 07:31

LONDON BRIEFING: Royal Mail Shares Hit By Ofcom Accusation

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.